marijuana stock news

Primco Management Inc. (PMCM)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue –   46   45   12  
Cost of Revenue 44 6 24 0
Gross Profit (44) 40   21   12  
Operating Expenses
Research Development – – – –
Selling General and Administrative 401 372 307 237
Non Recurring – – – –
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (445) (332) (285) (226)
Income from Continuing Operations
Total Other Income/Expenses Net 30 – – –
Earnings Before Interest And Taxes (415) (332) (285) (226)
Interest Expense (4,431) 9,146 2,901 196
Income Before Tax 4,016 (9,478) (3,186) (422)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops 4,046 (9,478) (3,186) (422)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income 4,016   (9,478) (3,186) (422)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares 4,016   (9,478) (3,186) (422)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$XXII Provides Highlights from Annual Shareholder Meeting

22nd Century Group Provides Highlights from Annual Shareholder Meeting Key Topics Include:…

$MCIG Announces Preliminary Record Numbers for Third Quarter

mCig, Inc. Announces Preliminary Record Numbers for Third Quarter   mCig, Inc.…

$ CTCO) Gains Positive Research Report by SeeThruEquity

Peak Pharmaceuticals Receives Favorable Research Report by SeeThruEquity  BOULDER, CO–(Marketwired – Jan…

$INSY to Present at Jefferies 2015 Healthcare Conference

Insys Therapeutics to Present at Jefferies 2015 Healthcare Conference Insys Therapeutics, Inc.…